BIIB

BIIB · Biogen Inc. Common Stock

View on chart

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Biogen sees kidney therapy progress and rating upgrade. Biogen is receiving attention after a kidney transplant milestone was reported, highlighting its involvement in kidney disease research. The company’s partner Estuary Therapeutics raised $93 million to advance a gene‑therapy for kidney disease, adding to the pipeline focus. Analysts have upgraded Biogen’s outlook, noting growth potential beyond its Alzheimer’s products. An earnings preview also points to upcoming results that could shape market views.

this person other insiders at BIIB

Insiders & Stakes

BIOGEN INC.
10% Owner
17,652,466
Shares held
Michel Vounatsos
Chief Executive Officer
67,261
Shares held
Susan H. Alexander
EVP Chief Legal Off & Corp Sec
41,807
Shares held
Caroline Dorsa
Director
31,002
Shares held
Christopher Viehbacher
President and CEO
29,924
Shares held
Eric K. Rowinsky
Director
25,844
Shares held
Michael R. McDonnell
EVP, Chief Financial Officer
24,341
Shares held
Ginger Gregory
EVP, Human Resources
22,359
Shares held
Nicole Murphy
Head of Pharm Ops and Tech
19,611
Shares held
Stephen A. Sherwin
Director
15,193
Shares held
Alexander J. Denner
Director
15,099
Shares held
Richard Mulligan
Director
15,099
Shares held
Robin Kramer
Chief Accounting Officer
11,472
Shares held
Jesus B. Mantas
Director
11,263
Shares held
Rachid Izzar
Head of Alzheimer's Disease
11,011
Shares held
William A. Hawkins
Director
10,365
Shares held
Stelios Papadopoulos
Director
10,095
Shares held
Maria C. Freire
Director
8,820
Shares held
Priya Singhal
Head of Development
8,043
Shares held
Chirfi Guindo
Head of Glob Prod Strat & Com
7,364
Shares held
Susan Langer
Director
6,634
Shares held
Adam Keeney
Head of Corporate Development
6,365
Shares held
Monish D. Patolawala
EVP, CFO & Transformation Off
5,215
Shares held
Galdes Alphonse
EVP Pharmaceutical Oper & Tech
5,064
Shares held
Jane Grogan
Head of Research
4,058
Shares held
Menelas N. Pangalos
Director
3,875
Shares held
Lloyd Minor
Director
2,689
Shares held
JONES WILLIAM D /CA/
Director
2,145
Shares held
Sean Godbout
Chief Accounting Officer
1,459
Shares held

Transaction History

Sean Godbout▲ Buy$0
Sean Godbout▼ Sell$2K
Lloyd Minor▼ Sell$119K
Lloyd Minor▼ Sell$121K
William A. Hawkins▲ Buy$0
Stephen A. Sherwin▲ Buy$0
Eric K. Rowinsky▲ Buy$0
Jesus B. Mantas▲ Buy$0
Susan Langer▲ Buy$0
Monish D. Patolawala▲ Buy$0
Menelas N. Pangalos▲ Buy$0
Menelas N. Pangalos▲ Buy$0
Lloyd Minor▲ Buy$0
Maria C. Freire▲ Buy$0
Adam Keeney▲ Buy$0
Adam Keeney▼ Sell$85K
Sean Godbout▲ Buy$0
Sean Godbout▼ Sell$10K
Nicole Murphy▲ Buy$585
Priya Singhal▼ Sell$532K
Nicole Murphy▼ Sell$205K
Susan H. Alexander▼ Sell$187K
Nicole Murphy▲ Buy$0
Nicole Murphy▼ Sell$184K
Nicole Murphy▲ Buy$0
Nicole Murphy▼ Sell$283K
Robin Kramer▲ Buy$0
Robin Kramer▼ Sell$55K
Robin Kramer▲ Buy$0
Robin Kramer▼ Sell$42K
Robin Kramer▲ Buy$0
Robin Kramer▼ Sell$214K
Adam Keeney▲ Buy$0
Adam Keeney▼ Sell$118K
Adam Keeney▲ Buy$0
Ginger Gregory▲ Buy$0
Ginger Gregory▼ Sell$134K
Ginger Gregory▲ Buy$0
Ginger Gregory▼ Sell$228K
Sean Godbout▲ Buy$0
Sean Godbout▼ Sell$15K
Sean Godbout▲ Buy$0
Sean Godbout▼ Sell$21K
Sean Godbout▲ Buy$0
Sean Godbout▼ Sell$36K
Susan H. Alexander▲ Buy$0
Susan H. Alexander▼ Sell$213K
Susan H. Alexander▲ Buy$0
Christopher Viehbacher▲ Buy$0
Christopher Viehbacher▼ Sell$876K
Christopher Viehbacher▲ Buy$0
Christopher Viehbacher▼ Sell$1.3M
Priya Singhal▲ Buy$0
Priya Singhal▼ Sell$212K
Priya Singhal▲ Buy$0
Priya Singhal▼ Sell$284K
Nicole Murphy▲ Buy$0
Adam Keeney▼ Sell$200K
Rachid Izzar▲ Buy$0
Rachid Izzar▼ Sell$162K
Rachid Izzar▲ Buy$0
Rachid Izzar▼ Sell$92K
Rachid Izzar▲ Buy$0
Rachid Izzar▼ Sell$156K
Jane Grogan▲ Buy$0
Jane Grogan▼ Sell$82K
Jane Grogan▲ Buy$0
Jane Grogan▼ Sell$117K
Ginger Gregory▲ Buy$0
Ginger Gregory▼ Sell$159K
Susan H. Alexander▲ Buy$0
Susan H. Alexander▼ Sell$305K
Priya Singhal▼ Sell$134K
Priya Singhal▲ Buy$0
Priya Singhal▼ Sell$105K
Christopher Viehbacher▲ Buy$0
Christopher Viehbacher▼ Sell$605K
Jane Grogan▲ Buy$0
Jane Grogan▼ Sell$52K
Sean Godbout▲ Buy$0
Sean Godbout▼ Sell$1K
Priya Singhal▼ Sell$69K
Priya Singhal▲ Buy$0
Priya Singhal▼ Sell$107K
Rachid Izzar▼ Sell$300K
Lloyd Minor▲ Buy$0
Susan Langer▲ Buy$0
William A. Hawkins▲ Buy$0
Jesus B. Mantas▲ Buy$0
Maria C. Freire▲ Buy$0
Eric K. Rowinsky▲ Buy$0
Caroline Dorsa▲ Buy$0
Monish D. Patolawala▲ Buy$0
Stephen A. Sherwin▲ Buy$0
Priya Singhal▼ Sell$481K
Caroline Dorsa▲ Buy$152K
Adam Keeney▲ Buy$0
Adam Keeney▼ Sell$55K
Stephen A. Sherwin▼ Sell$1.3M
Priya Singhal▲ Buy$0
Priya Singhal▼ Sell$51K
Nicole Murphy▲ Buy$0
Nicole Murphy▼ Sell$96K
Michael R. McDonnell▲ Buy$0
Michael R. McDonnell▼ Sell$195K
Robin Kramer▲ Buy$0
Robin Kramer▼ Sell$35K
Ginger Gregory▲ Buy$0
Ginger Gregory▼ Sell$90K
Susan H. Alexander▲ Buy$0
Susan H. Alexander▼ Sell$115K
Rachid Izzar▲ Buy$0
Rachid Izzar▼ Sell$63K
Jane Grogan▲ Buy$0
Adam Keeney▲ Buy$0
Adam Keeney▼ Sell$80K
Robin Kramer▲ Buy$0
Robin Kramer▼ Sell$33K
Robin Kramer▲ Buy$0
Robin Kramer▼ Sell$34K
Nicole Murphy▲ Buy$0
Nicole Murphy▼ Sell$88K
Nicole Murphy▲ Buy$0
Nicole Murphy▼ Sell$85K
Priya Singhal▲ Buy$0
Priya Singhal▼ Sell$96K
Jane Grogan▼ Sell$63K
Rachid Izzar▼ Sell$80K
Rachid Izzar▲ Buy$0
Michael R. McDonnell▲ Buy$0
Michael R. McDonnell▼ Sell$111K
Michael R. McDonnell▲ Buy$0
Michael R. McDonnell▼ Sell$101K
Christopher Viehbacher▲ Buy$0
Christopher Viehbacher▼ Sell$452K
Rachid Izzar▲ Buy$0
Rachid Izzar▼ Sell$85K
Ginger Gregory▲ Buy$0
Ginger Gregory▼ Sell$68K
Ginger Gregory▲ Buy$0
Ginger Gregory▼ Sell$79K
Susan H. Alexander▲ Buy$0
Susan H. Alexander▼ Sell$91K
Susan H. Alexander▲ Buy$0
Susan H. Alexander▼ Sell$84K
Priya Singhal▲ Buy$0
Priya Singhal▼ Sell$83K
Priya Singhal▼ Sell$17K
Priya Singhal▲ Buy$0
Priya Singhal▼ Sell$33K
Robin Kramer▲ Buy$0
Robin Kramer▼ Sell$27K
Susan H. Alexander▼ Sell$0
Susan H. Alexander▼ Sell$0
Jane Grogan▼ Sell$35K
Jane Grogan▲ Buy$0
Priya Singhal▼ Sell$88K
Priya Singhal▲ Buy$0
Priya Singhal▼ Sell$165K
Stephen A. Sherwin▲ Buy$0
Jesus B. Mantas▲ Buy$0
Eric K. Rowinsky▲ Buy$0
Susan Langer▲ Buy$0
William A. Hawkins▲ Buy$0
Maria C. Freire▲ Buy$0
Caroline Dorsa▲ Buy$0
Monish D. Patolawala▲ Buy$0
Adam Keeney▲ Buy$0
Adam Keeney▼ Sell$60K
Priya Singhal▼ Sell$20K
Nicole Murphy▲ Buy$0
Nicole Murphy▼ Sell$25K
Priya Singhal▼ Sell$58K
Ginger Gregory▼ Sell$336K
Ginger Gregory▼ Sell$160K
Rachid Izzar▲ Buy$0
Rachid Izzar▼ Sell$140K
Michael R. McDonnell▲ Buy$0
Nicole Murphy▲ Buy$0
Nicole Murphy▼ Sell$91K
Nicole Murphy▲ Buy$0
Nicole Murphy▼ Sell$43K
Priya Singhal▲ Buy$0
Priya Singhal▼ Sell$65K
Priya Singhal▲ Buy$0
Priya Singhal▼ Sell$38K
Ginger Gregory▲ Buy$0
Susan H. Alexander▲ Buy$0
Susan H. Alexander▼ Sell$363K
Susan H. Alexander▲ Buy$0
Susan H. Alexander▼ Sell$171K
Ginger Gregory▲ Buy$0
Michael R. McDonnell▼ Sell$241K
Priya Singhal▼ Sell$24K
Rachid Izzar▲ Buy$0
Rachid Izzar▼ Sell$69K
Robin Kramer▲ Buy$0
Robin Kramer▼ Sell$59K
Robin Kramer▲ Buy$0
Robin Kramer▼ Sell$28K

We use analytics to understand how market-wall is used. No personal data is sold.